Dr. Matteo Lambertini explains how Lynkuet reduced hot flashes in people on endocrine therapy for breast cancer, no matter when their treatment began.
News|Articles|September 24, 2026
7 Breast Cancer Clinical Trials Currently Enrolling in the US
Author(s)Spencer Feldman
Fact checked by: Quincy Attobrah
These seven breast cancer clinical trials are recruiting patients now, spanning early-stage, HR-positive, HER2-positive and triple-negative disease.
Advertisement
Advertisement
For people newly diagnosed with breast cancer or living with disease that has progressed, a clinical trial can open the door to treatments not yet available anywhere else. Below are seven trials actively recruiting participants across the country right now, covering early-stage disease through heavily pretreated metastatic cancer. Eligibility criteria are complex and vary by site, so anyone interested should talk with their care team about whether one of these studies might be a fit.
Related to this article
A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.
A woman treated for DCIS breast cancer with a double mastectomy shares why her smoother recovery left her with survivor guilt and feeling like an impostor.
Dr. Sara Hurvitz explains why giving Enhertu before surgery didn't change care for HER2-low, HR-positive early breast cancer, and what patients should know.
A breast cancer survivor shares how cancer turned gratitude into an everyday practice and why it's OK when the holidays bring both joy and grief this year.
Dr. Hope S. Rugo explains what KEYNOTE-B49 found about adding Keytruda to chemotherapy for PD-L1-positive, HR-positive, HER2-negative breast cancer.
Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, kidney cancer, colorectal cancer and stomach and esophageal cancer kept helping patients years later.
Among U.S. adults with a history of cancer, 45.8% reported drinking alcohol in the past 30 days in both 2016 and 2024, while drinking declined among adults without cancer, according to a study in Cancer Causes & Control of nearly 4 million adults.
Advertisement
Advertisement